BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24722187)

  • 1. Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death.
    Husseiny MI; Kaye A; Zebadua E; Kandeel F; Ferreri K
    PLoS One; 2014; 9(4):e94591. PubMed ID: 24722187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes.
    Husseiny MI; Kuroda A; Kaye AN; Nair I; Kandeel F; Ferreri K
    PLoS One; 2012; 7(10):e47942. PubMed ID: 23144715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase Gene May Be a More Suitable Target Than the Insulin Gene for Detection of β Cell Death.
    Sklenarova J; Petruzelkova L; Kolouskova S; Lebl J; Sumnik Z; Cinek O
    Endocrinology; 2017 Jul; 158(7):2058-2065. PubMed ID: 28525638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA.
    Fisher MM; Perez Chumbiauca CN; Mather KJ; Mirmira RG; Tersey SA
    Endocrinology; 2013 Sep; 154(9):3476-81. PubMed ID: 23825129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β cell death and dysfunction during type 1 diabetes development in at-risk individuals.
    Herold KC; Usmani-Brown S; Ghazi T; Lebastchi J; Beam CA; Bellin MD; Ledizet M; Sosenko JM; Krischer JP; Palmer JP;
    J Clin Invest; 2015 Mar; 125(3):1163-73. PubMed ID: 25642774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of β cell death in diabetes using differentially methylated circulating DNA.
    Akirav EM; Lebastchi J; Galvan EM; Henegariu O; Akirav M; Ablamunits V; Lizardi PM; Herold KC
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19018-23. PubMed ID: 22074781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes.
    Syed F; Tersey SA; Turatsinze JV; Felton JL; Kang NJ; Nelson JB; Sims EK; Defrance M; Bizet M; Fuks F; Cnop M; Bugliani M; Marchetti P; Ziegler AG; Bonifacio E; Webb-Robertson BJ; Balamurugan AN; Evans-Molina C; Eizirik DL; Mather KJ; Arslanian S; Mirmira RG
    Clin Epigenetics; 2020 Jul; 12(1):116. PubMed ID: 32736653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice.
    Rui J; Deng S; Lebastchi J; Clark PL; Usmani-Brown S; Herold KC
    Diabetologia; 2016 May; 59(5):1021-9. PubMed ID: 26910463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect.
    Zhang K; Lin G; Han Y; Xie J; Li J
    Clin Epigenetics; 2017; 9():44. PubMed ID: 28450972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.
    Brawerman G; Pipella J; Thompson PJ
    Mol Metab; 2022 Aug; 62():101524. PubMed ID: 35660116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells.
    Neiman D; Gillis D; Piyanzin S; Cohen D; Fridlich O; Moss J; Zick A; Oron T; Sundberg F; Forsander G; Skog O; Korsgren O; Levy-Khademi F; Arbel D; Hashavia S; Shapiro AMJ; Speake C; Greenbaum C; Hosford J; Posgai A; Atkinson MA; Glaser B; Schatz DA; Shemer R; Dor Y
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.
    Stefan-Lifshitz M; Karakose E; Cui L; Ettela A; Yi Z; Zhang W; Tomer Y
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA.
    Okada A; Yamada-Yamashita M; Tominaga Y; Jo K; Mori H; Suzuki R; Ishizu M; Tamaki M; Akehi Y; Takashi Y; Koga D; Shimokita E; Tanihara F; Kurahashi K; Yoshida S; Mitsui Y; Masuda S; Endo I; Aihara KI; Kagami S; Abe M; Ferreri K; Fujitani Y; Matsuhisa M; Kuroda A
    J Diabetes Investig; 2022 Jul; 13(7):1140-1148. PubMed ID: 35396829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset.
    Cechin SR; Lopez-Ocejo O; Karpinsky-Semper D; Buchwald P
    IUBMB Life; 2015 Aug; 67(8):634-44. PubMed ID: 26099053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes.
    Olsen JA; Kenna LA; Spelios MG; Hessner MJ; Akirav EM
    PLoS One; 2016; 11(4):e0152662. PubMed ID: 27111653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of β-cell death in type 1 diabetes by droplet digital PCR.
    Usmani-Brown S; Lebastchi J; Steck AK; Beam C; Herold KC; Ledizet M
    Endocrinology; 2014 Sep; 155(9):3694-8. PubMed ID: 25004096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-mediated pancreatic overexpression of
    Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
    Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
    Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
    Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
    Melanitou E
    Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.